top of page
No holds–barred!
Clinical holds are lost battles in the war against drug attrition. The process of drug development critically revolves around the FDA’s...
0 comments
Thymus up: the hidden powers of HCAC7
Some autoimmune diseases, like lupus, affect multiple tissues, but some, like inflammatory bowel disease, affect only specific types. A...
0 comments
Reducing safety-related drug attrition . . . the old-fashioned way
Everyone knows that off-targets are the bane of a drug developers existence, but surprisingly little has been done to address the...
0 comments
Blog: Blog
bottom of page